ATOS
ATOS
NASDAQ · Biotechnology

Atossa Therapeutics Inc

$1.96
+0.02 (+1.03%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +329.6% upside
Low Target $5.85
Average Target $8.42
High Target $9.99
Current Price $1.96
Current
$1.96
Target
$8.42
$5.85 $8.42 avg $9.99
Scenario Analysis
Bear Case
$5.85
198.5%
Low target
Base Case
$8.42
+329.6%
Avg target
Bull Case
$9.99
+409.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$14.85
-86.8% from high
52-Week Low
$1.70
+15.3% from low
Target vs 52W High
$8.42
-43.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%